Literature DB >> 7420997

[Reproducibility of central visual field testing using kinetic or computerized static perimetry (author's transl)].

E Gramer, M Pröll, G K Krieglstein.   

Abstract

Under controlled conditions the differences between duplicated examinations with the Goldmann kinetic perimeter and the Krakau/Heijl static computerized perimeter were evaluated. Kinetic visual fields were obtained independently by two well trained examiners and duplicate examinations were performed by computer perimetry. The differences between the two examinations were statistically evaluated using quantitative criteria. The agreement between first and second examination--based on normal and pathologic findings--was 72% for the Goldmann and 88% for the computer perimeter. The greater reproducibility of central visual field testing with the computer perimeter is most probably due to the subjectivity of the observer in the kinetic manual technique. The computer obviously represents a standardized observer using a constant strategy with a fixed time course. The computerized perimeter was easy to operate and did not require a specially trained technician. All the patients in whom kinetic visual field testing was possible were able to undergo computerized perimetry.

Entities:  

Mesh:

Year:  1980        PMID: 7420997     DOI: 10.1055/s-2008-1057464

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  3 in total

1.  Pattern electroretinogram and visually evoked cortical potentials in glaucoma.

Authors:  N Papst; M Bopp; O E Schnaudigel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1984       Impact factor: 3.117

2.  Performance of computer assisted perimeters.

Authors:  E L Greve
Journal:  Doc Ophthalmol       Date:  1982-12-01       Impact factor: 2.379

3.  The prognosis of glaucoma investigated with computerized perimetry.

Authors:  R de Natale; E Glaab-Schrems; G K Krieglstein
Journal:  Doc Ophthalmol       Date:  1984-12-15       Impact factor: 2.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.